Treace Medical Concepts, Inc.(TMCI)
Orthopedic Implants & Devices
Orthopedic Implants & Devices
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | Treace John T. Chief Executive Officer | Purchase | +24,606 | +0.20%12,583,726 | $4.03 | $99,196 | View SEC filing | |
| 2026-06-11 | Treace John T. Chief Executive Officer | Purchase | +52,317 | +0.42%12,559,120 | $4.03 | $210,968 | View SEC filing | |
| 2026-06-01 | Treace John T. Chief Executive Officer | Purchase | +50,000 | +0.40%12,506,803 | $3.56 | $177,915 | View SEC filing | |
| 2026-05-28 | Treace John T. Chief Executive Officer | Purchase | +115,520 | +0.94%12,456,803 | $2.95 | $340,589 | View SEC filing | |
| 2026-05-14 | Treace John T. Chief Executive Officer | Purchase | +153,763 | +1.26%12,341,283 | $2.44 | $375,505 | View SEC filing | |
| 2025-03-19 | Scanlan Sean F. Chief Innovation Officer | Sale | -50,000 | -12.07%364,081 | $7.97 | $398,460 | View SEC filing | |
| 2025-03-04 | Treace John T. Chief Executive Officer | Purchase | +60,000 | +0.50%12,120,319 | $8.73 | $524,064 | View SEC filing | |
| 2024-09-17 | Treace John T. Chief Executive Officer | Purchase | +50,000 | +0.42%11,847,224 | $5.31 | $265,630 | View SEC filing | |
| 2024-08-19 | TREACE JAMES T Director | Purchase | +84,000 | +4.95%1,779,624 | $5.96 | $501,035 | View SEC filing | |
| 2024-08-15 | Treace John T. Chief Executive Officer | Purchase | +85,000 | +0.73%11,797,224 | $6.00 | $510,315 | View SEC filing | |
| 2024-06-11 | Treace John T. Chief Executive Officer | Purchase | +45,000 | +0.39%11,712,224 | $5.88 | $264,600 | View SEC filing | |
| 2024-06-03 | TREACE JAMES T Director | Purchase | +25,000 | +1.50%1,695,624 | $6.05 | $151,328 | View SEC filing | |
| 2024-05-30 | TREACE JAMES T Director | Purchase | +25,000 | +1.52%1,670,624 | $5.20 | $130,063 | View SEC filing | |
| 2024-05-29 | TREACE JAMES T Director | Purchase | +50,000 | +3.13%1,645,624 | $5.07 | $253,475 | View SEC filing | |
| 2024-05-28 | MOTT RICHARD W Director | Purchase | +18,000 | +1.71%1,072,944 | $5.19 | $93,501 | View SEC filing | |
| 2024-05-23 | MOTT RICHARD W Director | Purchase | +12,100 | +1.16%1,054,944 | $4.99 | $60,425 | View SEC filing | |
| 2024-05-20 | Treace John T. Chief Executive Officer | Purchase | +100,000 | +0.86%11,667,224 | $5.56 | $556,170 | View SEC filing | |
| 2024-05-14 | Kiernan Jane E Director | Purchase | +19,356 | +346.57%24,941 | $5.17 | $100,001 | View SEC filing | |
| 2024-05-14 | Treace John T. Chief Executive Officer | Purchase | +150,000 | +1.31%11,567,224 | $5.12 | $767,805 | View SEC filing | |
| 2024-05-13 | Jain Deepti Director | Purchase | +25,000 | +400.96%31,235 | $4.50 | $112,568 | View SEC filing | |
| 2024-05-13 | MOTT RICHARD W Director | Purchase | +120,000 | +13.22%1,027,753 | $4.51 | $540,939 | View SEC filing | |
| 2024-05-13 | TREACE JAMES T Director | Purchase | +228,000 | +16.67%1,595,624 | $4.54 | $1,034,004 | View SEC filing | |
| 2024-05-13 | BAKEWELL JOHN K Director | Purchase | +130,000 | +37.43%477,348 | $4.57 | $594,620 | View SEC filing | |
| 2024-05-13 | Treace John T. Chief Executive Officer | Purchase | +300,000 | +2.70%11,417,224 | $4.57 | $1,370,370 | View SEC filing | |
| 2024-03-29 | TREACE JAMES T Director | Sale | -50,000 | -3.04%1,592,624 | $20.29 | $1,014,692 | View SEC filing |
1-25 of 132